<DOC>
	<DOCNO>NCT02184871</DOCNO>
	<brief_summary>The aim present study perform comprehensive molecular characterization intrahepatic cholangiocarcinoma ( ICC ) patient expose well-known putative risk factor ( asbestos ) malignancy , order identify possible `` molecular signature '' associate different risk factor .</brief_summary>
	<brief_title>Next Generation Sequencing Intrahepatic Cholangiocarcinoma</brief_title>
	<detailed_description>Exposure distinct risk factor enrol ICC patient assess modify ReNaM questionnaire . Molecular characterization ICC tissue sample carry RNAseq . Briefly , surgical resection tissue sample immediately suspend RNAlater . RNAseq analysis perform Illumina HiScanSQ platform . Any possible mutation identify RNAseq validate Sanger sequence . Putative identified fusion transcript confirm RT-PCR , use specific primer pair locate sequence exon two putative fusion gene . Variations gene expression validate real-time PCR . The bioinformatic analysis make use CentOS5 Server . For evaluation asbestos fiber tumor tissue , sample embed paraffin incinerate analyze scan electron microscope EDS spectroscopy .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<criteria>patient confirm diagnosis ICC resect ; patient sign informed consent ; patient ( male female ) least 18 year old . patient treat medical treatment ( chemotherapy experimental standard ) radiotherapy last 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>intrahepatic cholangiocarcinoma</keyword>
	<keyword>RNAseq</keyword>
	<keyword>risk factor</keyword>
	<keyword>asbestos</keyword>
</DOC>